DUBLIN--(BUSINESS WIRE)--The "Global Migraine Market: Industry Analysis & Outlook (2017-2021)" report has been added to Research and Markets' offering.
The report "Global Migraine Market: Industry Analysis & Outlook (2017-2021)" analyses the development of this market, with focus majorly on the U.S. market.
The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Amgen Inc., Eli Lilly and Company, Teva Pharmaceuticals & Alder Biopharmaceuticals are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global migraine market along with the study of the regional markets.
The global migraine market is set to experience favourable growth driven by factors such as increasing female population & increasing cigarette consumption. Further, the scope of growth for this market will be broadened by rising healthcare expenditure and accelerating economic growth. However, growth of this budding market will be hindered by limitations of current migraine therapies, regulatory challenges and high cost associated with migraine drugs.
- Growing Female Population
- Increasing Cigarette Consumption
- Rising HealthCare Expenditure
- Accelerating Economic Growth
- Increasing Prevalence of Headache Disorder
Key Trends & Development
- Drugs Under Pipeline for Migraine
- Technological Advancements
- Increasing Awareness for Migraine
- Limitations of Current Migraine Therapies
- Regulatory Challenges
- High Cost Associated
Key Topics Covered:
2. Global Market Analysis
3. Regional Market
4. Market Dynamics
6. Company Profiles
- Alder Biopharmaceuticals
- Amgen Inc.
- Eli Lilly and Company
- Teva Pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/research/dh9b36/global_migraine